Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

New psoriasis treatments are effective but come with side effects and risks.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Hair loss can be an early sign of HIV infection.

SCD1 is important for hair growth by keeping the connection in skin cells where hair stem cells live stable.

Hair loss treatment caused more hair loss in a man.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Pigs without the Hairless gene showed skin and thymus changes, useful for studying human hair disorders.

AIDS may cause changes in the scalp that increase infection risk and hair loss.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The document explains various skin conditions and their treatments.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

Certain drugs can cause skin lupus, but stopping the drug usually helps. Vaccines work against smallpox, genital herpes, and a type of human papillomavirus. More frequent light therapy clears psoriasis faster. Certain treatments work for psoriasis and dermatitis. A specific cream effectively treats a type of skin cancer. Low iron levels aren't directly linked to chronic hair loss.

Integrin alphavbeta6 is important for wound healing and hair growth, and blocking it may improve these processes.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.